These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10728680

  • 1. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
    Ni Z, Lou W, Leman ES, Gao AC.
    Cancer Res; 2000 Mar 01; 60(5):1225-8. PubMed ID: 10728680
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.
    Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938
    [Abstract] [Full Text] [Related]

  • 3. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
    Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC.
    Prostate; 2004 Sep 01; 60(4):303-9. PubMed ID: 15264241
    [Abstract] [Full Text] [Related]

  • 4. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R.
    Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264
    [Abstract] [Full Text] [Related]

  • 5. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 6. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.
    Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T.
    Oncogene; 2004 Jun 17; 23(28):4921-9. PubMed ID: 15077160
    [Abstract] [Full Text] [Related]

  • 7. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R.
    Mol Cancer Res; 2007 Aug 17; 5(8):823-32. PubMed ID: 17699108
    [Abstract] [Full Text] [Related]

  • 8. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice.
    DeMiguel F, Lee SO, Lou W, Xiao X, Pflug BR, Nelson JB, Gao AC.
    Prostate; 2002 Jul 01; 52(2):123-9. PubMed ID: 12111703
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH, Manoharan HT, Church DR, Dreckschmidt NE, Zhong W, Oberley TD, Wilding G, Verma AK.
    Cancer Res; 2007 Sep 15; 67(18):8828-38. PubMed ID: 17875724
    [Abstract] [Full Text] [Related]

  • 10. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H.
    Oncogene; 2002 Mar 27; 21(13):2000-8. PubMed ID: 11960372
    [Abstract] [Full Text] [Related]

  • 11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO, Lou W, Johnson CS, Trump DL, Gao AC.
    Prostate; 2004 Aug 01; 60(3):178-86. PubMed ID: 15176047
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL, Jiang Z, Savarese DM, Savarese TM.
    Am J Pathol; 2001 Jan 01; 158(1):25-32. PubMed ID: 11141475
    [Abstract] [Full Text] [Related]

  • 14. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
    Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ.
    Cancer Res; 2004 Sep 15; 64(18):6603-9. PubMed ID: 15374974
    [Abstract] [Full Text] [Related]

  • 15. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF, Murphy TF, Shu P, Barton AB, Barton BE.
    Mol Cancer; 2005 Jan 12; 4(1):2. PubMed ID: 15647107
    [Abstract] [Full Text] [Related]

  • 16. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Buettner R, Mora LB, Jove R.
    Clin Cancer Res; 2002 Apr 12; 8(4):945-54. PubMed ID: 11948098
    [Abstract] [Full Text] [Related]

  • 17. Stat3 activation in prostatic carcinomas.
    Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao AC.
    Prostate; 2002 Jun 01; 51(4):241-6. PubMed ID: 11987152
    [Abstract] [Full Text] [Related]

  • 18. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.
    Junicho A, Matsuda T, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H, Muraguchi A.
    Biochem Biophys Res Commun; 2000 Nov 11; 278(1):9-13. PubMed ID: 11071847
    [Abstract] [Full Text] [Related]

  • 19. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC, DeWille JW.
    Prostate; 2005 May 01; 63(2):143-54. PubMed ID: 15486993
    [Abstract] [Full Text] [Related]

  • 20. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway.
    Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y, Chiba T.
    Oncogene; 2003 Jan 30; 22(4):548-54. PubMed ID: 12555068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.